Global Osteoporosis Treatment Market By Treatment (Bisphosphonates – Alendronate (Binosto, Fosamax), Ibandronate (Boniva), Risedronate (Actonel, Atelvia), Zoledronic acid, Denosumab, Hormone-related therapy, Bone-building medications – Teriparatide, Abaloparatide, Romosozumab, Others); By Route of Administration (Oral, Intravenous); By Gender (Men, Women); By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospitals and clinics); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030